$NOVO B #Novo Nordisk A/S B Novo Nordisk - A stellar amylin piece to the obesity puzzle: Impressive ph1 results with AM833+semaglutide combo… …and similarly for the ph2 monotherapy trial with AM833 Another important &amp; positive step in… https://t.co/oXrxTTztzT #equity #stocks https://t.co/wYtbiwMzRy